rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Travis Whitfill

Chief Operating Officer

Company insider

Files Form 4 as: Chief Operating Officer, Azitra; Director, IN8bio.

In numbers

Trades disclosed
12
Buys
1
Sells
0
Bought
$4,500
Sold
$0
Companies
2
Companies where not an officer
1
First trade
29 Jul 2021
Last trade
20 Apr 2026
Last filed
22 Apr 2026

Companies traded

Where they are an officer
AZTR AzitraDirector, Officer · Biotechnology · last 20 Apr 20261 buy · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
INAB IN8bioDirector · Biotechnology · last 19 Dec 20240 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
20 Apr 2026filed 22 Apr 2026AZTR Azitraoption or derivative · BiotechnologySEC FORM 4 Code A—64,300 at $0.00filing
20 Apr 2026filed 22 Apr 2026AZTR Azitraoption or derivative · BiotechnologySEC FORM 4 Code A—64,300 at $0.00filing
19 Dec 2025filed 22 Dec 2025AZTR Azitraoption or derivative · BiotechnologySEC FORM 4 Code A—23,724 at $0.00filing
19 Dec 2024filed 23 Dec 2024INAB IN8biooption or derivative · BiotechnologySEC FORM 4 Code A—42,676 at $0.00filing
12 Jun 2024filed 14 Jun 2024INAB IN8biooption or derivative · BiotechnologySEC FORM 4 Code A—33,650 at $0.00filing
13 Feb 2024filed 15 Feb 2024AZTR AzitraBiotechnologySEC FORM 4 Bought$4,50015,000 at $0.30filing
8 Sep 2023filed 3 Oct 2023AZTR Azitraoption or derivative · BiotechnologySEC FORM 4 Code A—10,000 at $0.00filing
21 Jun 2023filed 23 Jun 2023AZTR AzitraBiotechnologySEC FORM 4 Code A$1,250250 at $5.00filing
15 Jun 2023filed 16 Jun 2023INAB IN8biooption or derivative · BiotechnologySEC FORM 4 Code A—85,000 at $0.00filing
1 Jun 2022filed 23 Sep 2022INAB IN8biooption or derivative · BiotechnologySEC FORM 4 Code A—13,500 at $0.00filing
1 Jun 2022filed 14 Jun 2022INAB IN8biooption or derivative · BiotechnologySEC FORM 4 Code A—10,500 at $0.00filing
29 Jul 2021filed 2 Aug 2021INAB IN8biooption or derivative · BiotechnologySEC FORM 4 Code A—10,500 at $0.00filing

News

Azitra (NYSEAMERICAN:AZTR) Shares to Reverse Split on Monday, October 26thAZTR · tickerreport.com · 18 Oct 2026Azitra, Inc. (NYSEAMERICAN:AZTR) Stock Short Interest Declines 65.7%AZTR · themarketsdaily.com · 15 Oct 2026

0 headlines in the last 90 days name Travis Whitfill; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care1

Buys in green, sells in red, by the company’s sector.

Related people

Francisco D. SalvaPresident and CEO · President and CEO at Azitra, filing Form 4 there in the last year
Norm StaskeyChief Financial Officer · Chief Financial Officer at Azitra, filing Form 4 there in the last year
John R. SchroerChief Financial Officer · Director at Azitra, filing Form 4 there in the last year
Barbara RyanDirector · Director at Azitra, filing Form 4 there in the last year